Albany Molecular Research Inc (AMRI.O)
18 Aug 2017
BRIEF-AMRI announces early termination of HSR waiting period for Carlyle Group, GTCR's proposed acquisition
* AMRI announces early termination of Hart-Scott-Rodino waiting period for the Carlyle Group and GTCR's proposed acquisition of AMRI
Contract drug manufacturer and research company Albany Molecular Research Inc said on Tuesday it had agreed to be taken private by buyout firms Carlyle Group LP and GTCR LLC for about $922 million in cash.
* Albany Molecular shares jump as much as 8.9 pct (Adds analyst comment)
* AMRI signs definitive agreement to be acquired by the Carlyle Group and GTCR for $21.75 per share in cash
June 6 Contract research company Albany Molecular Research Inc said on Tuesday it would be bought by private equity firms Carlyle Group LP and GTCR LLC for about $922 million in cash.
June 5 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday:
Buyout firms GTCR LLC and Carlyle Group LP are in talks to team up and jointly acquire U.S. contract drug manufacturer and researcher Albany Molecular Research Inc , people familiar with the matter said on Monday.
* Albany Molecular Research Inc - company confirms 2017 financial guidance
BRIEF-Albany Molecular Research enters into agreement with pharmaceutical group Ferrer, Accord Healthcare
* Albany Molecular Research Inc - entered into an agreement with pharmaceutical group Ferrer and Accord Healthcare, Inc.
* AMRI announces fourth quarter and full year 2016 results and provides 2017 outlook
|Johnson & Johnson (JNJ.N)||$132.63||-0.41|
|Abbott Laboratories (ABT.N)||$48.74||-0.55|
|Bristol-Myers Squibb Co (BMY.N)||$56.42||-0.35|
|Bristol-Myers Squibb Co (BMYMP.PK)||$1,050.00||--|
|Amgen, Inc. (AMGN.OQ)||$167.29||-0.52|
|Merck KGaA (MRCG.DE)||€91.01||-1.75|
|Gilead Sciences, Inc. (GILD.OQ)||$72.11||-0.23|
|Biogen Inc (BIIB.OQ)||$281.77||-2.65|
|Celgene Corporation (CELG.OQ)||$127.65||+0.07|
|Forest Laboratories, Inc. (FRX.N)||--||--|